Company Overview of N-Gene Research Laboratories, Inc.
N-Gene Research Laboratories, Inc. operates as a diabetes research biopharmaceutical company. The company primarily focuses in the areas of metabolic disorders. Its product include BGP-15, an oral antidiabetic drug with added cardiovascular and metabolic benefits, which is used for the treatment of type 2 diseases, monotherapy, and combination treatment; and antischizophrenics, attenuation of insulin resistance, and weight gain. N-Gene Research Laboratories, Inc. was founded in 1997 and is based in New York, New York.
575 Madison Avenue
New York, NY 10022
Founded in 1997
Key Executives for N-Gene Research Laboratories, Inc.
Similar Private Companies By Industry
|Quest Vision Technology, Inc.||United States|
|Alta Devices, Inc.||United States|
|Presidio Pharmaceuticals, Inc.||United States|
|Warrick Pharmaceuticals Corporation||United States|
|Three Rivers Pharmaceuticals, LLC||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
|Company Name||Geographic Region|
|NYC2012, Inc.||United States|
|Lawyers Committee for Civil Rights Under Law||United States|
|Rush University||United States|
|Greater Houston Partnership||United States|
Post a JobJobs
- Cayey | Becton DickinsonPosted: Dec 23
- Hyattsville, MD | University of Maryland University CollegePosted: Mar 04
- New York, NY | Black Harbor CapitalPosted: Mar 15
- San Francisco, CA | Marina Sirras & AssociatesPosted: Mar 13
Sponsored Financial Commentaries
To contact N-Gene Research Laboratories, Inc., please visit www.ngene.us. Company data is provided by Capital IQ. Please use this form to report any data issues.